{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:32:09Z","timestamp":1786375929785,"version":"build-2736575974"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently recognised autoinflammatory disease caused by somatic mutations in UBA1. Its clinical features include recurrent fever, systemic inflammation affecting multiple organs, and progressive haematologic abnormalities such as macrocytic anaemia. Because these manifestations overlap with other autoinflammatory diseases, including adult-onset Still\u2019s disease, the diagnosis can be challenging. In this case report, we describe a patient initially diagnosed with adult-onset Still\u2019s disease who was ultimately found to have VEXAS syndrome 5 years later due to progressive macrocytic anaemia. The patient developed recurrent fever and skin rash but did not have macrocytic anaemia at onset. Over the subsequent 5 years, his mean corpuscular volume progressively increased. Bone marrow biopsy revealed no evidence of malignancy but showed vacuoles in myeloid and erythroid progenitor cells. Based on these findings, VEXAS syndrome was suspected, and UBA1 testing identified the pathogenic p.Met41Thr variant, thereby confirming the diagnosis. This case highlights that macrocytic anaemia may not be present in the early phase of VEXAS syndrome. In patients diagnosed with adult-onset Still\u2019s disease who later develop or progressively worsen macrocytic anaemia, clinicians should consider VEXAS syndrome and perform UBA1 variant testing.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag067","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:50:25Z","timestamp":1783770625000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive macrocytic anaemia over 14\u00a0years leading to the diagnosis of VEXAS syndrome in a patient initially diagnosed with adult-onset Still\u2019s disease"],"prefix":"10.1093","volume":"10","author":[{"given":"Kazuya","family":"Abe","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, Matsudo City General Hospital , Chiba ,","place":["Japan"]},{"name":"Department of Allergy and Clinical Immunology, Chiba University Hospital , Chiba ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2157-3783","authenticated-orcid":false,"given":"Kentaro","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Matsudo City General Hospital , Chiba ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Matsuki","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Matsudo City General Hospital , Chiba ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Zaimoku","sequence":"additional","affiliation":[{"name":"Innovative Clinical Research Center, Kanazawa University Hospital , Kanazawa ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Umibe","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Matsudo City General Hospital , Chiba ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"2026081011271273500_ref1","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"2026081011271273500_ref2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/ard-2023-224460","article-title":"Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism","volume":"82","author":"Mascaro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026081011271273500_ref3","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S2665-9913(25)00034-7","article-title":"Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study","volume":"7","author":"Al-Hakim","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"2026081011271273500_ref4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2026081011271273500_ref5","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1136\/annrheumdis-2024-eular.3990","article-title":"Challenges in recognizing VEXAS syndrome: delayed diagnosis, misdiagnosis, and specific gene mutations associations","volume":"83","author":"Garcia","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026081011271273500_ref6","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"2026081011271273500_ref7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10238-025-01832-7","article-title":"Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failure","volume":"25","author":"Zaimoku","year":"2025","journal-title":"Clin Exp Med"},{"key":"2026081011271273500_ref8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/ard-2024-225640","article-title":"Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX","volume":"83","author":"Hadjadj","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026081011271273500_ref9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/mr\/roaf095","article-title":"High glucocorticoid dependency and limited therapeutic response in Japanese patients with VEXAS syndrome: a multicentre retrospective study","volume":"36","author":"Maeda","year":"2026","journal-title":"Mod Rheumatol"},{"key":"2026081011271273500_ref10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/rheumatology\/kead697","article-title":"Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment","volume":"64","author":"Johansen","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026081011271273500_ref11","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/rheumatology\/kead425","article-title":"Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome","volume":"63","author":"Maeda","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026081011271273500_ref12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/art.43287","article-title":"American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel","volume":"78","author":"Mekinian","year":"2026","journal-title":"Arthritis Rheumatol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag067\/68760790\/rxag067.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag067\/68760790\/rxag067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag067\/68760790\/rxag067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:27:19Z","timestamp":1786375639000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag067\/8732749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag067","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag067"}}